论文部分内容阅读
2009年末,美国临床肿瘤学会(ASCO)列出本年度15项重大研究进展,其中3项涉及胃肠肿瘤,包括靶向治疗以及基因检测。今天,靶向治疗作为临床关注的热点问题,临床医生更应该具有清醒的认识。尽管靶向药物临床应用已有20年的历史,其临床获益的研究也不断见诸文献报道,但仍然不能达到替代化疗以及任何一种形式的传统治疗水平,尤其是外科手术对于胃肠肿瘤最为重要的治疗地位不可动摇。
In late 2009, the American Society of Clinical Oncology (ASCO) listed 15 major research advances this year, three of which involved gastrointestinal tumors, including targeted therapies and genetic testing. Today, targeted therapy as a hot issue of clinical concern, clinicians should have a clear understanding. Although the clinical use of targeted drugs has been around for 20 years, and its clinical benefit has been continuously reported in the literature, it still can not meet the traditional chemotherapy and any form of traditional treatment, especially surgery for gastrointestinal tumors The most important treatment status can not be shaken.